Education
About Us
Working with TipRanks
Follow Us
Brii Biosciences Limited (HK:2137)
:2137
2137 Stock Chart & Stats
HK$1.57
HK$0.04(3.74%)
At close: 4:00 PM EST
HK$1.57
HK$0.04(3.74%)
Day’s Range― - ―
52-Week RangeHK$0.80 - HK$3.09
Previous CloseN/A
Volume2.92M
Average Volume (3M)6.36M
Market Cap
€1.37B
Enterprise Value-HK$1.10B
Total Cash (Recent Filing)€2.07B
Total Debt (Recent Filing)€7.39M
Price to Earnings (P/E)―
Beta1.50
Next Earnings
Mar 20, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding733,500,060
10 Day Avg. Volume5,897,564
30 Day Avg. Volume6,360,478
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.25
Price to Sales (P/S)12.38
P/FCF Ratio-1.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Brii Biosciences Limited News
2137 FAQ
What was Brii Biosciences Limited’s price range in the past 12 months?
Brii Biosciences Limited lowest stock price was HK$0.80 and its highest was HK$3.09 in the past 12 months.
What is Brii Biosciences Limited’s market cap?
Brii Biosciences Limited’s market cap is €1.37B.
When is Brii Biosciences Limited’s upcoming earnings report date?
Brii Biosciences Limited’s upcoming earnings report date is Mar 20, 2026 which is in 97 days.
How were Brii Biosciences Limited’s earnings last quarter?
Brii Biosciences Limited released its earnings results on Aug 21, 2025. The company reported -HK$0.218 earnings per share for the quarter, beating the consensus estimate of -HK$0.295 by HK$0.076.
Is Brii Biosciences Limited overvalued?
According to Wall Street analysts Brii Biosciences Limited’s price is currently Overvalued.
Does Brii Biosciences Limited pay dividends?
Brii Biosciences Limited does not currently pay dividends.
What is Brii Biosciences Limited’s EPS estimate?
Brii Biosciences Limited’s EPS estimate is -0.07.
How many shares outstanding does Brii Biosciences Limited have?
Brii Biosciences Limited has 733,500,060 shares outstanding.
What happened to Brii Biosciences Limited’s price movement after its last earnings report?
Brii Biosciences Limited reported an EPS of -HK$0.218 in its last earnings report, beating expectations of -HK$0.295. Following the earnings report the stock price went down -0.49%.
Which hedge fund is a major shareholder of Brii Biosciences Limited?
Currently, no hedge funds are holding shares in HK:2137
Company Description
Brii Biosciences Limited
Brii Biosciences Limited (2137) is a biotechnology company focused on developing innovative therapeutics for infectious diseases, particularly in the areas of viral infections and antimicrobial resistance. The company operates in the biotechnology and pharmaceutical sectors, leveraging its proprietary technology platforms to develop novel treatments. Brii Biosciences is committed to addressing unmet medical needs and enhancing global health through its research and development of advanced biopharmaceutical products.
Technical Analysis
Genor Biopharma Holdings Limited
―
3D Medicines, Inc.
―
TOT BIOPHARM International Co. Ltd.
―
JW (Cayman) Therapeutics Co. Ltd.
―
Hightide Therapeutics Inc
―
Options Prices
Currently, No data available
---